However, studies in NSCLC highlight the role of TILs such as CD8+ FOXP3+ T-cells (a Treg subtype), CD8+ T-cells, and FOXP3+ T-cells. The gene discussed is FOXP3; the disease is non-small cell lung carcinoma.